EFA6 activates Arf6 and participates in its targeting to the Flemming body during cytokinesis  by Ueda, Tomoko et al.
FEBS Letters 587 (2013) 1617–1623journal homepage: www.FEBSLetters .orgEFA6 activates Arf6 and participates in its targeting to the Flemming
body during cytokinesis0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.03.042
⇑ Corresponding author. Fax: +81 75 753 4557.
E-mail address: kazunaka@pharm.kyoto-u.ac.jp (K. Nakayama).Tomoko Ueda a, Ayako Hanai a, Tomomi Takei a, Keiji Kubo a, Minako Ohgi a, Hiroyuki Sakagami b,
Senye Takahashi a, Hye-Won Shin a,c, Kazuhisa Nakayama a,⇑
aGraduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
bDepartment of Anatomy, Kitasato University School of Medicine, Sagamihara, Kanagawa 228-8555, Japan
cCareer-Path Promotion Unit for Young Life Scientists, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japana r t i c l e i n f o
Article history:
Received 25 February 2013
Revised 20 March 2013
Accepted 28 March 2013
Available online 18 April 2013
Edited by Kazuhiro Iwai
Keywords:
Arf6
Cleavage furrow
Cytokinesis
EFA6
Flemming body
PH domaina b s t r a c t
The small GTPase Arf6 is transiently associated with the ingressing cleavage furrow and subse-
quently targeted to the Flemming body during cytokinesis, suggesting its activation around the
cleavage furrow. Here, we show that EFA6 (exchange factor for Arf6) localizes on the cleavage fur-
row through its PH domain. Time-lapse analysis showed that both EFA6 and Arf6 are transiently
localized around the ingressing cleavage furrow, but only Arf6 is subsequently targeted to the Flem-
ming body. Expression of an EFA6 mutant suppresses Arf6 recruitment onto the Flemming body.
These results suggest that EFA6 participates in activation of Arf6 around the cleavage furrow during
cytokinesis.
Structured summary of protein interactions:
EFA6a and ARF6 colocalize by ﬂuorescence microscopy (View Interaction: 1, 2, 3)
GGA1 physically interacts with ARF6 by pull down (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The Arf (ADP-ribosylation factor) small GTPases participate in
various membrane trafﬁcking events. In mammals, there are six
Arf isoforms and many Arf-like proteins [1]. The Arf proteins can
be grouped into three classes based on sequence similarity: class
I, Arf1–Arf3 (humans lack Arf2); class II, Arf4 and Arf5; and class
III, Arf6. Among them, Arf1 and Arf6 are the best characterized to
date. Arf1 triggers the formation of coated carrier vesicles from
the Golgi apparatus and endosomes. Arf6 localizes to the plasma
membrane and the endosomal system, where it regulates endo-
some recycling and remodeling of actin cytoskeleton and mem-
branes [2,3]. In addition to these roles in interphase cells, Arf6 is
required for the ﬁnal phase of cytokinesis [4–7].
We have recently shown that Arf6 is transiently localized to the
ingressing cleavage furrow region, and subsequently recruited to
the Flemming body during late cytokinesis [6,8]. The Flemming
body is a dense structure in the overlapping region of antiparallel
microtubule bundles of the central spindle; it serves as a scaffold
for a wide variety of structural and regulatory proteins required
for completion of cytokinesis, including those implicated inmembrane trafﬁcking [9,10]. Furthermore, we have shown that
GTP-bound, but not GDP-bound, Arf6 is recruited to the Flemming
body through interaction with mitotic kinesin-like protein 1
(MKLP1) [6]; MKLP1 constitutes the centralspindlin complex along
with MgcRacGAP/Cyk4, localizes to the Flemming body and plays
an essential role in cytokinesis [11,12]. On the other hand, Joseph
et al. have recently proposed that Arf6 stabilizes the centralspind-
lin complex by competing with the 14-3-3 protein [7].
The recruitment of Arf6 to the Flemming body in late cytokine-
sis phase involves its local and timely activation. Like other GTPas-
es, Arfs cycle between a GDP-bound inactive state and a GTP-
bound active state; exchange of bound GDP for GTP is catalyzed
by guanine-nucleotide exchange factors (GEFs), while hydrolysis
of bound GTP to GDP is promoted by GTPase-activating proteins
[2]. All known Arf-GEFs contain a Sec7 catalytic domain. Fifteen
Arf-GEFs encoded in the human genome can be divided into ﬁve
subfamilies based on sequence similarity and domain organization
[13–15]. Among them, members of the cytohesin, EFA6 (exchange
factor for Arf6), and BRAG (brefeldin A-resistant Arf-GEF) subfam-
ilies have been implicated in Arf6 activation [13].
In this study, we systematically examined these Arf-GEFs, and
found that EFA6 becomes localized to the cleavage furrow and is
involved in local activation of Arf6 during cytokinesis. Unlike
Arf6, however, EFA6 is not targeted to the Flemming body.
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2.1. Antibodies and reagents
Sources of antibodies reagents are as follows: polyclonal rabbit
anti-Arf6, provided by Yasunori Kanaho (University of Tsukuba, Ja-
pan); monoclonal rat anti-a-tubulin, Abcam; monoclonal mouse
anti-b-tubulin (KMX-1), Millipore; monoclonal rat anti-HA
(3F10), Roche Applied Science; AlexaFluor-conjugated secondary
antibodies and phalloidin, Molecular Probes.
2.2. Plasmids
Human EFA6A cDNA (BC142643) was obtained from OPEN BIO-
SYSTEMS, and other EFA6 cDNAs were obtained by RT-PCR of hu-
man (for EFA6B) or mouse (for EFA6C and EFA6D) total RNAs.
cDNAs for cytohesins were obtained by RT-PCR of mouse mRNAs;
those for BRAGs were obtained by RT-PCR of mouse (for BRAG1
and BRAG2) or rat (for BRAG3) mRNAs. The cDNAs were subcloned
into pEGFP-C1 or pEGFP-C3 (Invitrogen), or pcDNA3-mCherry-C
(provided by Roger Tsien, UCSD). An expression vector for Arf6-
HA and Arf6-EGFP were described previously [6]. Site-directed
mutagenesis were performed using a QuikChange Mutagenesis
Kit (Agilent Technologies).2.3. RT-PCR analysis
Total RNAs of HeLa cells were reverse-transcribed to cDNAs
using random hexamers and a SuperScript III First-StrandFig. 1. Localization of EFA6 isoforms in interphase and during cytokinesis. (A and B) HeLa
d’’) were subjected to staining for b-tubulin (a’–d’). Representative images of cells in in
EGFP-EFA6A were subjected to staining with AlexaFluor555-phalloidin and with anti-b-Synthesis System (Invitrogen), and ampliﬁed with rTaq DNA Poly-
merase (TOYOBO) using speciﬁc primers (Table S1). The PCR prod-
ucts were conﬁrmed by agarose gel electrophoresis. For EFA6A and
EFA6C, the PCR products were extracted from the gel and con-
ﬁrmed by sequence analysis.
2.4. Cell culture, DNA transfection, and immunoﬂuorescence analysis
Culture of HeLa cells, transfection of expression plasmids, and
immunoﬂuorescence analysis were performed as described previ-
ously [16], except for detection of endogenous Arf6. For Arf6, cells
were ﬁxed with 10% TCA for 15 min on ice, permeabilized with
0.1% Triton X-100 in PBS for 5 min as described previously [6,8].
2.5. Time-lapse imaging
Cells were seeded on a collagen-coated 35-mm glass bottom
dish (Mat Tek) and grown to 30% conﬂuence. Cells were then trans-
fected with expression plasmids for Arf6-EGFP and mCherry-
EFA6A, and after 24 h placed on the microscope stage that had
been pre-warmed at 37 C. The cells were observed with an Axio-
vert 200M microscope (Carl Zeiss) equipped with EMCCD C9100-
02 (Hamamatsu Photonics). Images were acquired sequentially
every 1 min and analyzed using MetaMorph imaging software
(Molecular Devices).
2.6. Pulldown assay for active Arf6
GEF activity of EFA6 towards Arf6 in cells was determined as
previously described for detection of Arf-GEF activity of BIG2cells expressing mCherry-EFA6A (a–a’’), -EFA6B (b–b’’), -EFA6C (c–c’’), or -EFA6D (d–
terphase (A) and in late cytokinesis phase (B) are shown. (C) HeLa cells expressing
tubulin antibody followed by AlexaFluor647-conjugated secondary antibody.
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with an Arf6-HA vector together with either an EGFP-EFA6A or a
control EGFP vector, and subjected to pulldown using a GST fusion
of the GGA1(GAT) domain pre-bound to glutathione-Sepharose
beads (GE Healthcare Bioscience). The bound proteins were then
processed for immunoblot analysis using an anti-HA antibody.Fig. 2. Localization of various EFA6A constructs during cytokinesis. (A) Schematic
representation of the domain organization of EFA6A. The relative positions of E621,
R765, and K766 residues are indicated. The EFA6A(N + PH) and EFA6A(PH + C)
constructs encompass residues 1–901 and 730–1024, respectively. (B–E) HeLa cells
expressing EGFP-EFA6A(WT) (B–B’’), -EFA6A(N + PH) (C–C’’), -EFA6A(PH + C) (D–
D’’), or -EFA6A(R765E/K766E) (E–E’’) were subjected to staining for b-tubulin (B’–
E’). Representative images of cells in late cytokinesis are shown.3. Results
3.1. Transient localization of EFA6 to the cleavage furrow
To ﬁnd candidate(s) for Arf-GEFs involved in local activation of
Arf6 during cytokinesis, we ﬁrst systematically examined localiza-
tion of Arf-GEFs. The GBF/BIG subfamily of high-molecular weight
Arf-GEFs are predominantly localized to the Golgi apparatus and
endosomes, and activate class I and II Arfs, whereas the cytohesin,
EFA6 and BRAG subfamilies are primarily localized on the plasma
membrane and can activate Arf6 [13,15]. Therefore, we examined
localization of members of the latter subfamilies. When expressed
as mCherry-tagged proteins in HeLa cells, in interphase all mem-
bers of the EFA6 subfamily are associated with the plasma mem-
brane, in particular with membrane rufﬂing regions (Fig. 1A) as
reported previously for EFA6A [18]. In cells undergoing cytokinesis,
mCherry-EFA6A and -EFA6C, but not mCherry-EFA6B or -EFA6D,
are prominently found around the ingressing cleavage furrow
(Fig. 1B). Comparing cells stained for the contractile ring with phal-
loidin and for the central spindle with anti-b-tubulin indicated that
EFA6A becomes transiently localized to the cleavage furrow region,
but not to the Flemming body (Fig. 1C–C’’’). Essentially the same
results were obtained for EFA6C (data not shown). In contrast to
EFA6, none of the cytohesin or BRAG subfamily members exhibits
signiﬁcant localization to the cleavage furrow or the Flemming
body during cytokinesis (Fig. S1).
All members of the EFA6 subfamily have a Sec7 catalytic do-
main, a pleckstrin homology (PH) domain, and a coiled-region in
their C-terminal half (see Fig. 2A) [19,20]. Previous studies revealed
that mRNAs encoding EFA6A and EFA6C are expressed primarily in
the brain, EFA6B mRNA in non-neural tissues, and EFA6D mRNA in
all tissues examined [19–21]. No studies have yet examined the
expression of these genes in cultured cell lines. In order to establish
the physiological relevance of the localization of EFA6A and EFA6C
to the cleavage furrow region in HeLa cells, we performed RT-PCR
analysis and found that HeLa cells express mRNAs encoding all
EFA6 subfamily members (Fig. S2). Since EFA6A has been the most
extensively studied, we hereafter focus on EFA6A. We examined
exogenous ﬂuorescent protein-tagged EFA6A in the following
experiments, because we failed to raise antibodies that can detect
endogenous EFA6A or any other EFA6 member in immunoblot and
immunoﬂuorescence analyses (data not shown).
3.2. PH domain-dependent localization of EFA6 to the cleavage furrow
Previous studies showed that association of EFA6A with the
plasma membrane is mediated primarily by its PH domain, which
is located C-terminal to the Sec7 domain (see Fig. 2A) and was
shown to interact with PtdIns(4,5)P2 [22]. We therefore examined
whether the PH domain is required for the cleavage furrow locali-
zation of EFA6A. First, we attempted to determine whether the
EFA6A PH domain alone was sufﬁcient for localization to the fur-
row region; this attempt was unsuccessful, however, because
expression of the PH domain alone caused death of almost all of
the transfected cells for an unknown reason (data not shown). In
contrast, expression of a construct encompassing the N- or C-ter-
minal region in addition to the PH domain (Fig. 2A) does not detec-
tably affect cell viability. Both the EFA6A(N + PH) andEFA6A(PH + C) constructs are associated with the cleavage furrow
(Fig. 2C–C’’ and D–D’’) like EFA6A(WT) (Fig. 2B–B’’). Furthermore,
mutation of consecutive Arg and Lys residues in the PH domain
(Arg756 and Lys766 in human EFA6A, Fig. 2A), which are conserved
in all EFA6 members [19] and were shown to be critical for associ-
ation of the PH domain with the plasma membrane [22], abolishes
the cleavage furrow localization of the full-length EFA6A construct
(Fig. 2E–E’’). Taking into account previous reports showing that
PtdIns(4,5)P2 is concentrated at the cleavage furrow [23–25], these
observations indicate that the PH domain is responsible for associ-
ation of EFA6A with the cleavage furrow membrane.
3.3. Transient colocalization of EFA6 and Arf6 at the cleavage furrow
The above observations suggest that EFA6 is a prime candidate
for an Arf-GEF involved in activation of Arf6 around the ingressing
cleavage furrow. To explore this idea, we compared localization of
EGFP-EFA6A with that of endogenous Arf6 during cytokinesis. In
early cytokinesis phase, both EFA6A and Arf6 are found in the
cleavage furrow region (Fig. 3A–A’’’). As cytokinesis proceeds,
Arf6 becomes concentrated at the Flemming body as we have re-
cently reported [6], while EFA6A appears to be gradually delocal-
ized from the cleavage furrow (Fig. 3B–B’’’ and C–C’’’). To
demonstrate the behavioral difference between EFA6A and Arf6
Fig. 3. Comparison of localization of EFA6A and Arf6 during cytokinesis. (A–C) HeLa cells expressing EGFP-EFA6A were subjected to staining for Arf6 (A’–C’) and b-tubulin
(A’’–C’’). Images of EGFP-EFA6A (A–C) are arranged from early to late cytokinesis phases in temporal order. (D) HeLa cells expressing mCherry-EFA6A and Arf6-EGFP were
subjected to time-lapse recording. An image sequence from Supplemental Video S1 is shown.
1620 T. Ueda et al. / FEBS Letters 587 (2013) 1617–1623during cytokinesis, we then performed time-lapse analysis of cells
expressing mCherry-EFA6A and Arf6-EGFP (Fig. 3D and Video S1).
In metaphase, when the cell is spherical, both mCherry-EFA6A
and Arf6-EGFP are distributed uniformly on the plasma membrane
as well as throughout the cytoplasm (panel for 0:00). Both proteins
are subsequently concentrated at patches in the equatorial region
at the onset of cytokinesis (0:08), and become distributed in the
equatorial region concurrent with cleavage furrow ingression
(0:13–0:29). In later cytokinesis phase, Arf6-EGFP signals are
markedly concentrated at the Flemming body, while mCherry-
EFA6A signals fade away from the cleavage furrow and become
uniformly distributed throughout the plasma membrane (0:44–
1:24). After abscission of the intercellular bridge, Arf6-EGFP isincorporated into one of the daughter cells as a Flemming body
remnant as well as localized to punctate structures beneath the
plasma membrane (2:44), as we previously reported [6]. These
observations make it likely that Arf6 is activated by EFA6 at the
cleavage furrow and in turn recruited to the Flemming body.
3.4. Exogenously expressed EFA6 mutant prevents Arf6 from Flemming
body localization
To conﬁrm that local activation of Arf6 by EFA6 is required for
its localization to the Flemming body, we exploited an EFA6 mu-
tant constructed on the basis of structural data obtained from
other Arf-GEFs. All Arf-GEFs have an invariant Glu residue in their
Fig. 4. Exogenously expressed EFA6 mutant abolishes the Flemming body localization of Arf6. (A) The EFA6A(E621K) mutant lacks GEF activity towards Arf6. Lysates
prepared from HeLa cells co-expressing Arf6-HA and either EGFP-EFA6A(WT) or EFA6A(E621K) were subjected to pulldown using GST-GGA1(GAT) and immunoblot analysis
using anti-HA antibody. (B–F) Exogenous expression of EFA6A(E621K) abolishes the Flemming body localization of Arf6 in a manner dependent on cleavage furrow
association via its PH domain. HeLa cells expressing EGFP-EFA6A(WT) (B), -EFA6A(E621K) (C), -EFA6A(R765E/K766E) (D), or -EFA6A(E631K/R765E/K766E) (E) were subjected
to staining for Arf6 and b-tubulin. Representative images of cells in late cytokinesis are shown. (F) The cells in late cytokinesis in the experiments shown in (B–E) were
classiﬁed as with or without endogenous Arf6 signals at the Flemming body. Percentages of cells with the Arf6 signals at the Flemming body are expressed as bar graphs. Note
that, because not only the expression efﬁciency of the EFA6A(R765E/K766E) mutant but also the proportion of EFA6A(R765E/K766E)-expressing cells in cytokinesis was
extremely low, we could examine only a small number of EFA6A(R765E/K766E)-expressing cells, as compared with cells expressing other EFA6A(WT) constructs.
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the ‘glutamate ﬁnger’ plays a pivotal role in guanine nucleotide ex-
change on Arfs, and Arf-GEF mutants, where the Glu residue is re-
placed with Lys, inhibits GDP release from Arfs [26,27]. We
therefore constructed a Glu-to-Lys mutant (E621K) of EFA6A, and
asked whether its expression affects Arf6 localization.
We ﬁrst conﬁrmed that the EFA6A(E621K) mutant lacks GEF
activity by performing a pulldown assay with a GST fusion of the
GGA1-GAT domain, which detects GTP-bound, but not GDP-bound,
Arfs [16,17]. As shown in Fig. 4A, coexpression of EGFP-EFA6A(WT)
in HeLa cells signiﬁcantly increases the amount of Arf6-HA pulled
down with GST-GGA1-GAT as compared with the control, indicat-
ing that coexpressed EFA6A can activate Arf6 in the cell. In con-
trast, EGFP-EFA6A(E621K) expression does not increase the
amount of GTP-bound Arf6.
We next examined whether the catalytically inactive EFA6A
mutant has any effect on Arf6 localization. In cells expressing exog-
enous EGFP-EFA6A(WT), endogenous Arf6 is able to localize to the
Flemming body (Fig. 4B–B’’’), as in cells without exogenous EFA6
expression [6]. In striking contrast, in cells expressing EGFP-
EFA6A(E621K), Arf6 no longer associates with the cleavage furrow
nor the Flemming body in late cytokinesis phase (Fig. 4C-C’’’ and F),
indicating that Arf6 is locally activated by EFA6 and becomes tran-
siently associated with the furrow membrane, and is in turn re-
cruited onto the Flemming body through interacting with MKLP1
as described previously [6]. To examine whether the observed ef-
fect of EFA6A(E621K) is dependent on its cleavage furrow localiza-
tion, we then exploited mutations in two conserved basic residues
in the PH domain (R765E/K766E). The EFA6A(R765E/K766E) mu-
tant is not localized on the plasma membrane in interphase (data
not shown) nor to the cleavage furrow region during cytokinesis
(Fig. 4D–D’’’, also see Fig. 2E); furthermore, it does not affect the
Flemming body localization of Arf6 (Fig. 4D–D’’’). Introduction ofthe R765E/K766E mutations into the EFA6A(E621K) mutant also
abolished its localization to the cleavage furrow (Fig. 4E–E’’’). Nota-
bly, as compared with the EFA6A(E621K) mutant (Fig. 4C–C’’’),
exogenous EFA6A(E621K/R765E/K766E) expression does not have
a drastic effect on the Flemming body localization of Arf6 in late
cytokinesis phase (Fig. 4E–E’’’ and F). Thus, these results indicate
that the dominant effect of the EFA6A(E621K) mutant on the
Arf6 localization depends on its ability to associate with the plas-
ma membrane, probably at the cleavage furrow, through its PH
domain.4. Discussion
We have recently shown that Arf6 is transiently associated with
the cleavage furrow, and subsequently recruited to the Flemming
body in its GTP-bound state via interaction with MKLP1/KIF23; at
the furrow, Arf6 plays a role in successful completion of cytokinesis
[6,7]. The spatiotemporal change of Arf6 localization suggests that
it is activated at the cleavage furrow during cytokinesis. Here, we
extended these observations by demonstrating that EFA6 becomes
localized at the cleavage furrow membrane during cytokinesis
(Fig. 1). Arf6 also becomes localized to the cleavage furrow con-
comitant with the concentration of EFA6 there, suggesting that
Arf6 is activated by EFA6 at the furrow (see Fig. 5). Arf6 is in turn
targeted to the Flemming body. After abscission, Arf6 is incorpo-
rated into one of the daughter cells as a Flemming body remnant
along with MKLP1/KIF23 as we recently reported [6], while EFA6
becomes once again distributed throughout the plasma membrane
(Fig. 3C and Video S1). Furthermore, we showed that the
EFA6A(E621K) mutant, but not EFA6A(E621K/R765E/K766E), dom-
inantly inhibits Arf6 localization to the Flemming body. These
observations suggest that Arf6 activation by EFA6 at the cleavage
Fig. 5. A model for Arf6 activation by EFA6 and subsequent targeting to the
Flemming body. EFA6 is concentrated to the cleavage furrow membrane by
interacting with PtdIns(4,5)P2 via its PH domain, and promotes exchange of GDP
bound to Arf6 for GTP. The GTP-bound Arf6 is then recruited to the Flemming body
by interacting with preexisting MKLP1.
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furrow membrane through its PH domain (Fig. 4). We have also at-
tempted to show involvement of EFA6 in Arf6 activation and cyto-
kinesis by RNAi approach. Because EFA6 isoforms probably have a
redundant role, we have attempted simultaneous knockdown of
multiple EFA6 isoforms; the attempt, however, has so far been
unsuccessful, for lack of speciﬁc antibodies against EFA6 isoforms
to conﬁrm efﬁcient depletion of the EFA6 proteins. This is a future
issue to be addressed.
We propose a functional model (Fig. 5) integrating our data pre-
sented in this study with previously published works. Our model
suggests that the EFA6 recruitment to the cytoplasmic surface of
the cleavage furrow membrane determines the timing of Arf6 acti-
vation and its subsequent targeting to the Flemming body via
interaction with MKLP1/KIF23, although our results do not exclude
a possibility that other Arf-GEF(s) also contribute to the Arf6 acti-
vation. The association of EFA6A with the cleavage furrow is abol-
ished by a PH domain mutation (Fig. 4D), which also blocks its
association with the plasma membrane [22]. Since PtdIns(4,5)P2
and PtdIns4P 5-kinase, which catalyzes formation of PtdIns(4,5)P2
from PtdIns(4)P, are concentrated around the cleavage furrow [23–
25], the local generation of PtdIns(4,5)P2 may determine recruit-
ment of EFA6 to the cleavage furrow membrane and in turn local
activation of Arf6. Furthermore, we previously showed that Arf6
can activate PtdIns4P 5-kinase [28]. It is therefore tempting to
speculate that a local, small increase in the active Arf6 level maytrigger a subsequent ampliﬁcation in the signal via local activation
of PtdIns4P 5-kinase and a consequent increase in the PtdIns(4,5)P2
level. Future studies should address the link between local activa-
tion of Arf6 and regulation of phosphoinositide metabolism.
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